Entropy model for multiplex drug-target interaction endpoints of drug immunotoxicity

Current Topics in Medicinal Chemistry

Volumn 13, Issue 14, 2013, Pages 1636-1649

  Tenorio Borroto, Esvieta ^a,b   García Mera, Xerardo ^a   Peñuelas Rivas, Claudia G ^b   Vásquez Chagoyán, Juan C ^b   Prado Prado, Francisco J ^c   Castañedo, Nilo ^d   González Díaz, Humberto ^e,f  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b UNIVERSIDAD AUTÓNOMA METROPOLITANA   (Mexico)

^c UNIVERSIDAD DE QUINTANA ROO   (Mexico)

^d CENTRAL UNIVERSITY OF LAS VILLAS   (Cuba)

^e UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^f BASQUE FOUNDATION FOR SCIENCE   (Spain)

Author keywords

Drug immunotoxicity and cytotoxicity; Entropy; Flow cytometry; Multi target models

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIPARASITIC AGENT; COLONY STIMULATING FACTOR RECEPTOR; MACROPHAGE MIGRATION INHIBITION FACTOR;

ACCURACY; ANALYTICAL PARAMETERS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CULTURE; CELL VIABILITY; COMPUTER PREDICTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG RECEPTOR BINDING; ENTROPY; FEMALE; FLOW CYTOMETRY; HIGH THROUGHPUT SCREENING; HUMAN; IC 50; IMMUNOTOXICITY; MACROPHAGE; MATHEMATICAL MODEL; MOUSE; NONHUMAN; PROBABILITY; QUANTITATIVE STRUCTURE TOXICITY RELATION; SENSITIVITY AND SPECIFICITY; STRUCTURE ACTIVITY RELATION;

ANIMALS; CYTOTOXINS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; ENTROPY; HUMANS; IMMUNITY; MODELS, MOLECULAR; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84887917955     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/15680266113139990114     Document Type: Article

References (77)

1. Kier, L. B., Use of molecular negentropy to encode structure governing biological activity. J. Pharm. Sci, 1980, 69 (7), 807-10.
2. Agrawal, V. K.; Khadikar, P. V., Modelling of carbonic anhydrase inhibitory activity of sulfonamides using molecular negentropy. Bioorg. Med. Chem. Lett, 2003, 13 (3), 447-53.
3. Stahura, F. L.; Godden, J. W.; Bajorath, J., Differential Shannon entropy analysis identifies molecular property descriptors that predict aqueous solubility of synthetic compounds with high accuracy in binary QSAR calculations. J. Chem. Inf. Comput. Sci, 2002, 42 (3), 550-8.
4. Stahura, F. L.; Godden, J. W.; Xue, L.; Bajorath, J., Distinguishing between natural products and synthetic molecules by descriptor Shannon entropy analysis and binary QSAR calculations. J. Chem. Inf. Comput. Sci, 2000, 40 (5), 1245-52.
5. Roy, K.; Saha, A., Comparative QSPR studies with molecular connectivity, molecular negentropy and TAU indicesPart I: Molecular thermochemical properties of diverse functional acyclic compounds. J. Mol. Model, 2003, 9 (4), 259-70.
6. Agrawal, V. K.; Bano, S.; Khadikar, P. V., QSAR analysis of antibacterial activity of some 4-aminodiphenylsulfone derivatives. Acta Microbiol Immunol Hung 2003, 50 (4), 385-93.
7. Agrawal, V. K.; Karmarkar, S.; Khadikar, P. V., QSAR study on binding affinity of PATs (rodenticides) to the3H]-mepyramine-labelled H1 receptor in rat and guinea pig brain. SAR. QSAR. Environ. Res, 2001, 12 (6), 529-45.
8. Agrawal, V. K.; Khadikar, P. V., QSAR studies on acylated histamine derivatives. Bioorg Med Chem 2001, 9 (11), 2787-92.
9. Katritzky, A. R.; Lomaka, A.; Petrukhin, R.; Jain, R.; Karelson, M.; Visser, A. E.; Rogers, R. D., QSPR correlation of the melting point for pyridinium bromides, potential ionic liquids. J. Chem. Inf. Comput. Sci, 2002, 42 (1), 71-4.
10. Katritzky, A. R.; Perumal, S.; Petrukhin, R.; Kleinpeter, E., Codessa-based theoretical QSPR model for hydantoin HPLC-RT lipophilicities. J. Chem. Inf. Comput. Sci, 2001, 41 (3), 569-74.
11. Strait, B. J.; Dewey, T. G., The Shannon information entropy of protein sequences. Biophys J 1996, 71 (1), 148-55.
12. Dima, R. I.; Thirumalai, D., Proteins associated with diseases show enhanced sequence correlation between charged residues. Bioinformatics, 2004, 20 (15), 2345-54.
13. Loewenstern, D.; Yianilos, P. N., Significantly lower entropy estimates for natural DNA sequences. J. Comput. Biol, 1999, 6 (1), 125-42.
14. Manke, T.; Demetrius, L.; Vingron, M., Lethality and entropy of protein interaction networks. Genome Inform Ser 2005, 16 (1), 159-63.
15. Graham, D. J., Information Content in Organic Molecules: Brownian Processing at Low Levels. J Chem Inf Model 2007, 47 (2), 376-389.
16. Gonzalez-Diaz, H.; Prado-Prado, F.; Ubeira, F. M., Predicting antimicrobial drugs and targets with the MARCH-INSIDE approach. Curr Top Med Chem 2008, 8 (18), 1676-90.
17. Gonzalez-Diaz, H.; Duardo-Sanchez, A.; Ubeira, F. M.; Prado-Prado, F.; Perez-Montoto, L. G.; Concu, R.; Podda, G.; Shen, B., Review of MARCH-INSIDE & Complex Networks Prediction of Drugs: ADMET, Anti-parasite Activity, Metabolizing Enzymes and Cardiotoxicity Proteome Biomarkers. Curr. Drug. Metab, 2010, 11, 379-406.
18. Riera-Fernandez, P.; Munteanu, C. R.; Escobar, M.; Prado-Prado, F.; Martin-Romalde, R.; Pereira, D.; Villalba, K.; Duardo-Sanchez, A.; Gonzalez-Diaz, H., New Markov-Shannon Entropy models to assess connectivity quality in complex networks: from molecular to cellular pathway, Parasite-Host, Neural, Industry, and Legal-Social networks. J. Theor. Biol, 2012, 293, 174-88.
19. Diaz, H.; Marrero, Y.; Hernandez, I.; Bastida, I.; Tenorio, E.; Nasco, O.; Uriarte, E.; Castanedo, N.; Cabrera, M.; Aguila, E.; Marrero, O.; Morales, A.; Perez, M., 3D-MEDNEs: An alternative "in silico" technique for chemical research in toxicology. 1. Prediction of chemically induced agranulocytosis. Chem. Res. Toxicol, 2003, 16 (10), 1318-1327.
20. Cruz-Monteagudo, M.; González-Díaz, H.; Borges, F.; Dominguez, E. R.; Cordeiro, M. N., 3D-MEDNEs: an alternative "in silico" technique for chemical research in toxicology. 2. quantitative proteome-toxicity relationships (QPTR) based on mass spectrum spiral entropy. Chem. Res. Toxicol, 2008, 21 (3), 619-32.
21. 2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins. Eur. J. Med. Chem. 2011, 46 (12), 5838-51.
22. Gaulton, A.; Bellis, L. J.; Bento, A. P.; Chambers, J.; Davies, M.; Hersey, A.; Light, Y.; McGlinchey, S.; Michalovich, D.; Al-Lazikani, B.; Overington, J. P., ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res, 2012, 40, D1100-1107.
23. Heikamp, K.; Bajorath, J., Large-scale similarity search profiling of ChEMBL compound data sets. J. Chem. Info. Model, 2011, 51 (8), 1831-9.
24. StatSoft. Inc. STATISTICA (data analysis software system), version 6. 0, www. statsoft. com, Statsoft, Inc., 6. 0; 2002.
25. Van Waterbeemd, H., Chemometric methods in molecular design. Wiley-VCH: New York, 1995; Vol. 2.
26. Speck-Planche, A.; Kleandrova, V. V.; Luan, F.; Cordeiro, M. N., Multi-target drug discovery in anti-cancer therapy: fragment-based approach toward the design of potent and versatile anti-prostate cancer agents. Bioorg. Med. Chem, 2011, 19 (21), 6239-44.
27. Nom, S., Especificaciones técnicas para la producción, cuidado y uso de los animales de laboratorio. SENACICA, 1999, ZOO (62), 1-58.
28. Tario J. D., M. K. A., Pan Dalin., Munson Mark E., K, a. W. P., Tracking Immune Cell Proliferation and Cytotoxic Potential Using Flow Cytometry. In: Flow Cytometry Protocols, Methods in Molecular Biology, T. S. H. a. R. G. H., Ed. 2011.
29. González-Díaz, H.; Marrero, Y.; Hernandez, I.; Bastida, I.; Tenorio, E.; Nasco, O.; Uriarte, E.; Castanedo, N.; Cabrera, M. A.; Aguila, E.; Marrero, O.; Morales, A.; Perez, M., 3D-MEDNEs: an alternative "in silico" technique for chemical research in toxicology. 1. prediction of chemically induced agranulocytosis. Chem Res Toxicol 2003, 16 (10), 1318-27.
30. Gerets, H. H.; Dhalluin, S.; Atienzar, F. A., Multiplexing cell viability assays. Methods Mol. Biol. 2011, 740, 91-101.
31. Garcia-Garcia, A.; Galvez, J.; de Julian-Ortiz, J. V.; Garcia-Domenech, R.; Munoz, C.; Guna, R.; Borras, R., New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method. J. Antimicrob. Chemother, 2004, 53 (1), 65-73.
32. Martinez-Romero, M.; Vazquez-Naya, J. M.; Rabunal, J. R.; Pita-Fernandez, S.; Macenlle, R.; Castro-Alvarino, J.; Lopez-Roses, L.; Ulla, J. L.; Martinez-Calvo, A. V.; Vazquez, S.; Pereira, J.; Porto-Pazos, A. B.; Dorado, J.; Pazos, A.; Munteanu, C. R., Artificial intelligence techniques for colorectal cancer drug metabolism: ontology and complex network. Curr. Drug. Metab, 2010, 11 (4), 347-68.
33. Meinel, T.; Schweiger, M. R.; Ludewig, A. H.; Chenna, R.; Krobitsch, S.; Herwig, R., Ortho2 Express Matrix-a web server that interprets cross-species gene expression data by gene family information. BMC Genomics, 2011, 12, 483.
34. Oberg, T., A QSAR for baseline toxicity: validation, domain of application, and prediction. Chem. Res. Toxicol, 2004, 17 (12), 1630-7.
35. Gonzalez-Diaz, H.; Vilar, S.; Santana, L.; Podda, G.; Uriarte, E., On the applicability of QSAR for recognition of miRNA bioorganic structures at early stages of organism and cell development: embryo and stem cells. Bioorg. Med. Chem, 2007, 15 (7), 2544-50.
36. Papa, E.; Gramatica, P., Externally validated QSPR modelling of VOC tropospheric oxidation by NO3 radicals. SAR. QSAR Environ. Res, 2008, 19 (7-8), 655-68.
37. Taraviras, S. L.; Ivanciuc, O.; Cabrol-Bass, D., Identification of groupings of graph theoretical molecular descriptors using a hybrid cluster analysis approach. J. Chem. Inf. Comput. Sci, 2000, 40 (5), 1128-46.
38. Saiz-Urra, L.; González-Díaz, H.; Uriarte, E., Proteins Markovian 3D-QSAR with spherically-truncated average electrostatic potentials. Bioorg. Med. Chem, 2005, 13 (11), 3641-7.
39. Mei, H.; Liao, Z. H.; Zhou, Y.; Li, S. Z., A new set of amino acid descriptors and its application in peptide QSARs. Biopolymers, 2005, 80 (6), 775-86.
40. Jacobs, M. N., In silico tools to aid risk assessment of endocrine disrupting chemicals. Toxicology, 2004, 205 (1-2), 43-53.
41. Blondeau, J. M.; Castanedo, N.; Gonzalez, O.; Mendina, R.; Silveira, E., In vitro evaluation of G1: a novel antimicrobial compound. Int. J. Antimicrob. Agents, 1999, 11 (2), 163-6.
42. Marrero-Ponce Y, C.-G. J., Olazabal E, Serrano HS, Morales A, Castañedo N, Ibarra-Velarde F, Huesca-Guillen A, Sánchez AM, Torrens F, Castro EA, Atom, atom-type and total molecular linear indices as a promising approach for bioorganic and medicinal chemistry: theoretical and experimental assessment of a novel method for virtual screening and rational design of new lead anthelmintic. Bioorg. Med. Chem, 2005, 13 (4), 1005-20.
43. Perez Machado Giselle., G. B. J. I., Castañedo N., Creus A., and Marcos R., In vitro genotoxicity testing of the furylethylene derivative UC-245 in human cells. Mutagenesis, 2004, 19 (1), 75-80.
44. OECD, E. D., Guidance document on using cytotoxicity tests to estimate starting doses for acute oral systemic toxicity tests. OECD Series on Testing and Assessment, 2010, 20 (129), 1-54.
45. González Borroto JI, P. M. G., Creus A, Marcos R., Comparative genotoxic evaluation of 2-furylethylenes and 5-nitrofurans by using the comet assay in TK6 cells. Mutagenesis, 2005, 20 (3), 193-7.
46. Hernández, O.; Martinez, Y.; Pimentel, H.; Llanes, Y.; Pérez, G.; Vazquez, N.; Fernández, S.; Quesada, L.; Debesa, A., Effect of bromine atoms number on the cytotoxicity of two 2-furylethylene derivative substances in normal and tumoral cell lines. Electron. J. Biomed, 2012, 1, 26-36.
47. Cao LF, K. L., Tran V, Mi S, Jensen MC, Blanchard S, Kalos M., Development and application of a multiplexable flow cytometrybased assay to quantify cell-mediated cytolysis. Cytometry A. 2010, 77 (6), 534-45.
48. Riss TL, M. R., Use of multiple assay endpoints to investigate the effects of incubation time, dose of toxin, and plating density in cell-based cytotoxicity assays. Assay Drug Dev. Technol, 2004, 2 (1), 51-62.
49. Veselá R, D. L., Pytlík R, Rychtrmocová H, Mareková H, Trníní M., The evaluation of survival and proliferation of lymphocytes in autologous mixed leukocyte reaction with dendritic cells. The comparison of incorporation of (3)H-thymidine and differential gating method. Cell Immunol, 2011, 271 (11), 78-84.
50. Gorczyca W, S. Z., Cronin W, Li X, Mau S, Tugulea S., Immunophenotypic pattern of myeloid populations by flow cytometry analysis. Methods Cell Biol, 2011, 103, 221-66.
51. McGowan P, N. N., Wimmer J, Williams D, Wen J, Li M, Ewton A, Curry C, Zu Y, Sheehan A, Chang CC., Differentiating Between Burkitt Lymphoma and CD10+ Diffuse Large B-Cell Lymphoma: The Role of Commonly Used Flow Cytometry Cell Markers and the Application of a Multiparameter Scoring System. Am. J. Clin. Pathol, 2012, 137 (4), 665-70.
52. Su, X.; Rozmus, W.; Tsui, Y. Y., Wide-angle light-scattering differentiation of organelle-size particle distributions in whole cells. Cytometry A, 2010, 77 (6), 580-4.
53. Hirakawa, A.; Hamada, C.; Yoshimura, I., Sample size calculation through the incorporation of heteroscedasticity and dependence for a penalized t-statistic in microarray experiments. J Biopharm Stat 2012, 22 (2), 260-75.
54. Daye, Z. J.; Chen, J.; Li, H., High-Dimensional Heteroscedastic Regression with an Application to eQTL Data Analysis. Biometrics, 2012, 68 (1), 316-326.
55. Knijnenburg, T. A.; Roda, O.; Wan, Y.; Nolan, G. P.; Aitchison, J. D.; Shmulevich, I., A regression model approach to enable cell morphology correction in high-throughput flow cytometry. Mol. Syst. Biol, 2011, 7, 531.
56. Manivannan, E.; Prasanna, S., First QSAR report on FSH receptor antagonistic activity: quantitative investigations on physicochemical and structural features among 6-amino-4-phenyltetrahydroquinoline derivatives. Bioorg. Med. Chem. Lett, 2005, 15 (20), 4496-501.
57. Ganfon H, B. J., Tchinda AT, Gbaguidi F, Gbenou J, Moudachirou M, Frédérich M, Quetin-Leclercq J., Antiparasitic activities of two sesquiterpenic lactones isolated from Acanthospermum hispidum D. C. J. Ethnopharmacol, 2012.
58. Wert L, A. S., Corral MJ, Sánchez-Fortún S, Yli-Kauhaluoma J, Alunda JM., Toxicity of betulin derivatives and in vitro effect on promastigotes and amastigotes of Leishmania infantum and L. donovani. J Antibiot, 2011, 64 (7), 475-81.
59. Yilma, A. N.; Singh, S. R.; Fairley, S. J.; Taha, M. A.; Dennis, V. A., The Anti-Inflammatory Cytokine, Interleukin-10, Inhibits Inflammatory Mediators in Human Epithelial Cells and Mouse Macrophages Exposed to Live and UV-Inactivated Chlamydia trachomatis. Mediators Inflamm, 2012, 2012, 520174.
60. Shin KJ, W. E., Zavzavadjian JR, Santat LA, Liu J, Hwang JI, Rebres R, Roach T, Seaman W, Simon MI, Fraser ID., A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression. Proc. Natl. Acad. Sci. USA, 2006, 103 (37), 13759-64.
61. Danilkovitch-Miagkova, A.; Leonard, E. J., Cross-talk between RON receptor tyrosine kinase and other transmembrane receptors. Histol. Histopathol, 2001, 16 (2), 623-31.
62. Lutz, M. A.; Correll, P. H., Activation of CR3-mediated phagocytosis by MSP requires the RON receptor, tyrosine kinase activity, phosphatidylinositol 3-kinase, and protein kinase C zeta. J. Leukoc. Biol, 2003, 73 (6), 802-14.
63. Ray, M.; Yu, S.; Sharda, D. R.; Wilson, C. B.; Liu, Q.; Kaushal, N.; Prabhu, K. S.; Hankey, P. A., Inhibition of TLR4-induced I-B kinase activity by the RON receptor tyrosine kinase and its ligand, macrophage-stimulating protein. J Immunol, 2010, 185 (12), 7309-16.
64. Rampino, T.; Gregorini, M.; Bedino, G.; Piotti, G.; Gabanti, E.; Ibatici, A.; Sessarego, N.; Piacenza, C.; Balenzano, C. T.; Esposito, P.; Bosio, F.; Soccio, G.; Frassoni, F.; Dal Canton, A., Mesenchymal stromal cells improve renal injury in anti-Thy 1 nephritis by modulating inflammatory cytokines and scatter factors. Clin. Sci, 2011, 120 (1), 25-36.
65. Koebernick, H.; Grode, L.; David, J. R.; Rohde, W.; Rolph, M. S.; Mittrücker, H. W.; Kaufmann, S. H., Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium. Proc. Natl. Acad. Sci. U S A, 2002, 99 (21), 13681-6.
66. Rosado, J. e. D.; Rodriguez-Sosa, M., Macrophage migration inhibitory factor (MIF): a key player in protozoan infections. Int. J. Biol. Sci, 2011, 7 (9), 1239-56.
67. Stanley, E. R.; Berg, K. L.; Einstein, D. B.; Lee, P. S.; Pixley, F. J.; Wang, Y.; Yeung, Y. G., Biology and action of colonystimulating factor-1. Mol. Reprod. Dev, 1997, 46 (1), 4-10.
68. Shimaya, Y.; Shimada, M.; Shutto, Y.; Fujita, T.; Murakami, R.; Nakamura, N.; Yamabe, H.; Okumura, K., Thrombin stimulates synthesis of macrophage colony-stimulating factor, granulocytemacrophage colony-stimulating factor and granulocyte colonystimulating factor by human proximal tubular epithelial cells in culture. Nephron. Extra, 2012, 2 (1), 1-8.
69. Rademakers, R.; Baker, M.; Nicholson, A. M.; Rutherford, N. J.; Finch, N.; Soto-Ortolaza, A.; Lash, J.; Wider, C.; Wojtas, A.; De-Jesus-Hernandez, M.; Adamson, J.; Kouri, N.; Sundal, C.; Shuster, E. A.; Aasly, J.; MacKenzie, J.; Roeber, S.; Kretzschmar, H. A.; Boeve, B. F.; Knopman, D. S.; Petersen, R. C.; Cairns, N. J.; Ghetti, B.; Spina, S.; Garbern, J.; Tselis, A. C.; Uitti, R.; Das, P.; Van Gerpen, J. A.; Meschia, J. F.; Levy, S.; Broderick, D. F.; Graff-Radford, N.; Ross, O. A.; Miller, B. B.; Swerdlow, R. H.; Dickson, D. W.; Wszolek, Z. K., Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat. Genet, 2012, 44 (2), 200-205.
70. Menke, J.; Kriegsmann, J.; Schimanski, C. C.; Schwartz, M. M.; Schwarting, A.; Kelley, V. R., Autocrine CSF-1 and CSF-1 receptor coexpression promotes renal cell carcinoma growth. Cancer Res, 2012, 72 (1), 187-200.
71. Raycroft, M. T.; Harvey, B. P.; Bruck, M. J.; Mamula, M. J., Inhibition of antigen trafficking through scavenger receptor A. J. Biol. Chem, 2012, 287 (8), 5310-5316.
72. Kzhyshkowska, J.; Neyen, C.; Gordon, S., Role of macrophage scavenger receptors in atherosclerosis. Immunobiology, 2012, 217 (5), 492-502.
73. Khan, J. A.; Abdul Rahman, M. N.; Mazari, F. A.; Shahin, Y.; Smith, G.; Madden, L.; Fagan, M. J.; Greenman, J.; McCollum, P. T.; Chetter, I. C., Intraluminal thrombus has a selective influence on matrix metalloproteinases and their inhibitors (tissue inhibitors of matrix metalloproteinases) in the wall of abdominal aortic aneurysms. Ann. Vasc. Surg, 2012, 26 (3), 322-329.
74. Wei, P. C.; Tsai, C. H.; Chiu, P. S.; Lai, S. C., Matrix metalloproteinase-12 leads to elastin degradation in BALB/c mice with eosinophilic meningitis caused by Angiostrongylus cantonensis. Int. J. Parasitol, 2011, 41 (11), 1175-83.
75. Chou, P. H.; Lai, S. C., Elevated concentrations of matrix metalloproteinase-12 and elastin degradation products in the sera of pregnant women infected with Toxoplasma gondii. Ann. Trop. Med. Parasitol, 2011, 105 (3), 225-231.
76. Kahnert, A.; Seiler, P.; Stein, M.; Bandermann, S.; Hahnke, K.; Mollenkopf, H.; Kaufmann, S. H., Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis. Eur. J. Immunol, 2006, 36 (3), 631-647.
77. Marsland, B. J.; Kurrer, M.; Reissmann, R.; Harris, N. L.; Kopf, M., Nippostrongylus brasiliensis infection leads to the development of emphysema associated with the induction of alternatively activated macrophages. Eur. J. Immunol, 2008, 38 (2), 479-488.